Pulmonary or cardiac dysfunction in field-of-RT region — radiation contraindicated; ritux...
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
| ID | RF-NLPBL-ORGAN-DYSFUNCTION |
|---|---|
| Type | Red flag |
| Status | reviewed 2026-04-25 | pending_clinical_signoff |
| Diseases | DIS-NLPBL |
| Sources | SRC-ESMO-HODGKIN-2024 SRC-NCCN-BCELL-2025 |
Red Flag Origin
| Definition | Pulmonary or cardiac dysfunction in field-of-RT region — radiation contraindicated; rituximab monotherapy or systemic chemo alternative. |
|---|---|
| Clinical direction | de-escalate |
| Category | organ-dysfunction |
Trigger Logic
{
"any_of": [
{
"finding": "pulmonary_dysfunction_rt_field",
"value": true
},
{
"finding": "cardiac_dysfunction_rt_field",
"value": true
},
{
"comparator": "<",
"finding": "lvef_percent",
"threshold": 50
}
],
"type": "composite_clinical"
}
Notes
NLPBL is highly responsive to RT; field-of-RT organ dysfunction is the main contraindication. Rituximab monotherapy + observation acceptable alternative.
Used By
No reverse references found in the YAML corpus.